Press release
U.S. Addictions Therapeutics Market to Reach USD 29.8 Billion by 2034
U.S. Addictions Therapeutics Market
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/76072
Key Takeaways
• Market Size 2024: USD 14.6 Billion
• Forecast 2034: USD 29.8 Billion
• CAGR (2025-2034): 7.2%
• Therapy Types: Alcohol Addiction, Opioid Addiction, Tobacco/Nicotine Addiction, Stimulant Addiction, Others
• Key Drivers: Rising Substance Abuse, Biotech R&D Expansion, Federal Support Programs, and Digital Therapeutics Adoption
• Dominant Region: United States (global leader in addiction research & treatment)
• Major Players: Indivior PLC, Alkermes, Pfizer, Johnson & Johnson, Opiant Pharmaceuticals, BioCorRx, Titan Pharmaceuticals, Mallinckrodt Pharmaceuticals, Adial Pharmaceuticals, Pear Therapeutics
Market Story
The U.S. addictions therapeutics market is at a critical turning point, where medical innovation is reshaping traditional recovery frameworks. Driven by the ongoing opioid crisis and a rising number of cases related to alcohol, tobacco, and prescription drug misuse, the demand for pharmacological and behavioral intervention solutions continues to surge.
New drug development, expanding treatment centers, and the adoption of digital behavioral therapy platforms are revolutionizing patient outcomes. Biotech companies are increasingly leveraging AI-assisted molecule screening, CRISPR-based genetic insights, and mobile health applications to enhance treatment personalization and reduce relapse rates.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/76072/us-addictions-therapeutics-market
Segmentation Overview
• By Drug Type:
Alcohol Addiction Treatment Drugs, Nicotine Replacement Therapies (NRTs), Opioid Addiction Medications (Methadone, Buprenorphine, Naltrexone), Others
• By Treatment Type:
Pharmacotherapy, Behavioral Therapy, Combination Therapy
• By Distribution Channel:
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Rehabilitation Centers
• By End User:
Hospitals, Specialty Clinics, Rehab Centers, Research Institutes
Recent Developments
• Indivior PLC: Expanded its portfolio with Sublocade® (extended-release buprenorphine) to improve long-term opioid dependency management.
• Alkermes: Launched Vivitrol® across additional states under Medicaid coverage, boosting treatment accessibility.
• Pfizer & Pear Therapeutics: Collaborated on prescription digital therapeutics (PDTs) integrating behavioral health support apps.
• Titan Pharmaceuticals: Advanced trials for Probuphine®, an implantable formulation ensuring steady medication release.
• Adial Pharmaceuticals: Reported progress on AD04, a serotonin receptor modulator targeting alcohol addiction relapse prevention.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=76072
Expert Insight
"The fight against addiction is entering a scientific renaissance. Combining pharmacological precision with behavioral reinforcement and digital care platforms will transform the U.S. recovery landscape over the next decade," said Anurag Tiwari, Senior Life Sciences Analyst at Exactitude Consultancy.
Market Drivers
1. Surging Opioid Crisis: More than 2.1 million Americans suffer from opioid-related disorders, necessitating broad therapeutic interventions.
2. Government Initiatives: Federal grants under programs like SAMHSA and NIH accelerate adoption of new therapies and rehab frameworks.
3. Innovation in Drug Delivery: Long-acting injectables and implantable systems improve patient adherence and relapse prevention.
4. Rising Acceptance of Digital Therapeutics: FDA-approved mobile and AI-based behavioral therapy tools are redefining home-based recovery.
5. Growing Biotech Pipeline: Several U.S. startups are exploring anti-craving, neuroplasticity-enhancing, and immunotherapy-based drug candidates.
Forecast & Regional Insights
The U.S. dominates the global addiction therapeutics landscape due to high treatment awareness, advanced healthcare systems, and government backing. The ongoing integration of AI, neuroscience, and precision drug delivery is expected to push the boundaries of recovery outcomes.
By 2034, addiction therapy in the U.S. will evolve from symptomatic management toward personalized, data-driven, and hybrid (digital + pharmacological) care models-reshaping national strategies for rehabilitation and mental health.
Conclusion
The U.S. Addictions Therapeutics Market is on a transformative path powered by biotechnology, public health reforms, and digital innovation. As pharma companies and policymakers collaborate to tackle one of America's most persistent health challenges, the decade ahead will mark a decisive shift toward precision-based recovery solutions that combine empathy, science, and technology.
This report is also available in the following languages : Japanese (米国の依存症治療薬市場), Korean (미국 중독 치료 시장), Chinese (美国成瘾治疗市场), French (Marché américain des traitements contre la toxicomanie), German (US-Markt für Suchttherapien), and Italian (Mercato terapeutico delle dipendenze negli Stati Uniti), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/76072
Our More Reports:
Gastrointestinal Therapeutics Market
https://exactitudeconsultancy.com/reports/2915/gastrointestinal-therapeutics-market
Digital Therapeutics (DTx) Market
https://exactitudeconsultancy.com/reports/7904/digital-therapeutics-dtx-market
Biologics Safety Testing Market
https://exactitudeconsultancy.com/reports/28396/biologics-safety-testing-market
Chronic Lymphocytic Leukemia Therapeutics Market
https://exactitudeconsultancy.com/reports/28626/chronic-lymphocytic-leukemia-therapeutics-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Addictions Therapeutics Market to Reach USD 29.8 Billion by 2034 here
News-ID: 4261835 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
